Manufacturers’ Secrecy and Refusal to Recall Deadly Products Results in Deaths and Injuries
February 17, 2022The Food and Drug Administration (FDA) warned consumers and health care practitioners in early February 2023, not to purchase and to immediately stop using EzriCare Artificial Tears or Delsam Pharma’s Artificial Tears due to potential bacterial contamination. Using these contaminated products increases risk of eye infections that could result in blindness or death.
本月晚些时候,FDA 建议 Global Pharma 召回 Delsam Pharma 的人工眼膏,该公司同意启动召回所有未过期批次的 EzriCare 人工泪液和 Delsam Pharma 的人工泪液。 FDA 建议此次召回,因为该公司目前违反了良好生产规范 (CGMP) ,包括缺乏适当的微生物测试、配方问题(该公司在多用途瓶中生产和销售眼科药物,没有添加足够的防腐剂)以及缺乏对防篡改包装进行适当控制。
如果您因 Delsam Pharma 的 Ezricare 人工泪液受伤,请立即联系律师。